<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00645775</url>
  </required_header>
  <id_info>
    <org_study_id>GHAIGOB131CT</org_study_id>
    <nct_id>NCT00645775</nct_id>
  </id_info>
  <brief_title>Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome</brief_title>
  <official_title>The Efficacy of Irvingia Gabonensis (Bush Mango) in the Management of Overweight, Obesity and Metabolic Syndrome in Cameroon.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gateway Health Alliance</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Yaounde</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gateway Health Alliance</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigated the use and efficacy of the seeds of African bush mango (Irvingia
      gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the effects of seeds of Irvingia gabonensis on body weight, fasting blood glucose,
      plasma total and LDL cholesterol in 102 overweight and obese participants.

      The study was a 10 week randomized, double blind, placebo controlled design. participants
      were randomly divided into 2 groups of 51 participants each. Group 1 was the placebo group,
      while Group 2 was the active group. Each group received 2 daily doses of 125 mg (before
      meals) of either placebo or Irvingia gabonensis.

      Weight as well as fasting blood was taken at baseline and at 4, 8 and 10 weeks. No major
      detary changes or exercises were suggested during the study period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight change</measure>
    <time_frame>10 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in blood lipids and hormone levels</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Obesity</condition>
  <condition>Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Compare active to placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>IGOB131</intervention_name>
    <description>Comparison of 250 mg per day of Irvingia gabonensis to placebo</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI&gt;26

        Exclusion Criteria:

          -  Diabetics Pregnant and lactating Participating in any other weight reducing program
             Smokers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julius E Oben, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Gateway Health Alliances / University of Yaounde</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratory of Nutrition &amp; Nutritional Biochemistry</name>
      <address>
        <city>Yaounde</city>
        <state>Centre</state>
        <zip>BP812</zip>
        <country>Cameroon</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Cameroon</country>
  </location_countries>
  <verification_date>August 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2008</study_first_submitted>
  <study_first_submitted_qc>March 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2008</study_first_posted>
  <last_update_submitted>March 25, 2008</last_update_submitted>
  <last_update_submitted_qc>March 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2008</last_update_posted>
  <responsible_party>
    <name_title>Pr. Julius Oben, CSO</name_title>
    <organization>Gateway Health Alliances</organization>
  </responsible_party>
  <keyword>Weight loss</keyword>
  <keyword>Antiobesity</keyword>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Leptin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

